Loading

author: Paediatric Formulary Committee

2023-09-14

Pharmaceutical Press

Bnf For Children (Bnfc) 2023-2024

Easy Payment Plan
Easy Payment Plans
i
Same-day to 2-day delivery
Check availability in store
The first choice for concise medicines information for children.

Practical and evidence-based, BNF for Children (BNFC) is the only child-focused drug formulary in the world that is both independent, and has rigorous, accredited content creation processes. This edition provides up-to-date guidance on prescribing, dispensing, and administering medicines to children, plus legal and professional guidelines.

Relied on by health professionals who prescribe, dispense, and administer medicines to paediatrics, BNFC supports confident decision-making at the point of care. Including best practice guidelines and advice from a network of paediatric experts. The process is overseen by a paediatric formulary committee.

Extensive content updates in the new edition include:



22 new monographs
32 dose changes
42 other significant changes including safety alerts from the MHRA, and new and updated clinical guidance from the UK Health Security Agency and NICE

Published jointly by the British Medical Association, Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacy Group.
View full description
Loyalty dots logo
Earn 0 loyalty dots equivalent to BHD 0 when you sign-in and order
Easy Payment Plan
Easy Payment Plans
i
The first choice for concise medicines information for children.

Practical and evidence-based, BNF for Children (BNFC) is the only child-focused drug formulary in the world that is both independent, and has rigorous, accredited content creation processes. This edition provides up-to-date guidance on prescribing, dispensing, and administering medicines to children, plus legal and professional guidelines.

Relied on by health professionals who prescribe, dispense, and administer medicines to paediatrics, BNFC supports confident decision-making at the point of care. Including best practice guidelines and advice from a network of paediatric experts. The process is overseen by a paediatric formulary committee.

Extensive content updates in the new edition include:



22 new monographs
32 dose changes
42 other significant changes including safety alerts from the MHRA, and new and updated clinical guidance from the UK Health Security Agency and NICE

Published jointly by the British Medical Association, Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacy Group.
View full description
View less description

publisher

Pharmaceutical Press

Specifications

Books

Number of Pages
1352
Publication Date
2023-09-14
View more specifications
View less specifications
Customers